Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Sala

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
EMBO Molecular Medicine|July 30, 2016
A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cellsLuca Sala, Zhiyi Yu, Dorien Ward-van Oostwaard, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 12, 2026
Beyond Transconductance: Cell-Polymer Coupling Determines Fidelity in Action Potential Recording via Electrolyte-Gated Polymer TransistorsGiulia Zoe Zemignani, Elena Mancinelli, Gabriele Tullii, et al.
Communications Biology|March 19, 2023
A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytesClaudia Altomare, Chiara Bartolucci, Luca Sala, et al.
Cardiovascular Research|May 14, 2026
Machine learning-guided risk stratification for Long QT Syndrome genetic variants with hiPSC-derived cardiomyocytesAleksandr Khudiakov, Manuela Mura, Federica Giannetti, et al.
British Journal of Pharmacology|March 14, 2025
Rescue of loss-of-function long QT syndrome-associated mutations in K<sub>V</sub>7.1/KCNE1 by the endocannabinoid N-arachidonoyl-L-serine (ARA-S)Irene Hiniesto-Iñigo, Akshay Sridhar, Julien Louradour, et al.
Frontiers in Molecular Neuroscience|February 9, 2019
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic HistotypeLuca Sala, Giovanni Cirillo, Gabriele Riva, et al.
JNCI Cancer Spectrum|May 7, 2026
Sequential chemo-durvalumab, reduced dose RT, and consolidation durvalumab for unresectable stage III NSCLC unfit for PACIFIC regimen (DEDALUS trial)Francesco Agustoni, Jessica Saddi, Diego Luigi Cortinovis, et al.
Cardiovascular Research|August 21, 2014
Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertensionMarcella Rocchetti, Luca Sala, Riccardo Rizzetto, et al.
Cell Death Discovery|November 28, 2024
Cardiomyocyte and stromal cell cross-talk influences the pathogenesis of arrhythmogenic cardiomyopathy: a multi-level analysis uncovers DLK1-NOTCH pathway role in fibro-adipose remodellingAngela Serena Maione, Lara Iengo, Luca Sala, et al.
Cardiovascular Research|March 17, 2020
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genesYee-Ki Lee, Luca Sala, Manuela Mura, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
EMBO Molecular Medicine|July 30, 2016
A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cellsLuca Sala, Zhiyi Yu, Dorien Ward-van Oostwaard, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 12, 2026
Beyond Transconductance: Cell-Polymer Coupling Determines Fidelity in Action Potential Recording via Electrolyte-Gated Polymer TransistorsGiulia Zoe Zemignani, Elena Mancinelli, Gabriele Tullii, et al.
Communications Biology|March 19, 2023
A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytesClaudia Altomare, Chiara Bartolucci, Luca Sala, et al.
Cardiovascular Research|May 14, 2026
Machine learning-guided risk stratification for Long QT Syndrome genetic variants with hiPSC-derived cardiomyocytesAleksandr Khudiakov, Manuela Mura, Federica Giannetti, et al.
British Journal of Pharmacology|March 14, 2025
Rescue of loss-of-function long QT syndrome-associated mutations in K<sub>V</sub>7.1/KCNE1 by the endocannabinoid N-arachidonoyl-L-serine (ARA-S)Irene Hiniesto-Iñigo, Akshay Sridhar, Julien Louradour, et al.
Frontiers in Molecular Neuroscience|February 9, 2019
Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic HistotypeLuca Sala, Giovanni Cirillo, Gabriele Riva, et al.
JNCI Cancer Spectrum|May 7, 2026
Sequential chemo-durvalumab, reduced dose RT, and consolidation durvalumab for unresectable stage III NSCLC unfit for PACIFIC regimen (DEDALUS trial)Francesco Agustoni, Jessica Saddi, Diego Luigi Cortinovis, et al.
Cardiovascular Research|August 21, 2014
Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertensionMarcella Rocchetti, Luca Sala, Riccardo Rizzetto, et al.
Cell Death Discovery|November 28, 2024
Cardiomyocyte and stromal cell cross-talk influences the pathogenesis of arrhythmogenic cardiomyopathy: a multi-level analysis uncovers DLK1-NOTCH pathway role in fibro-adipose remodellingAngela Serena Maione, Lara Iengo, Luca Sala, et al.
Cardiovascular Research|March 17, 2020
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genesYee-Ki Lee, Luca Sala, Manuela Mura, et al.
Pageof 9